These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
184 related items for PubMed ID: 23221107
1. Intermittent administration of human parathyroid hormone before osteosynthesis stimulates cancellous bone union in ovariectomized rats. Tsuchie H, Miyakoshi N, Kasukawa Y, Aonuma H, Shimada Y. Tohoku J Exp Med; 2013 Jan; 229(1):19-28. PubMed ID: 23221107 [Abstract] [Full Text] [Related]
4. The effects of combined human parathyroid hormone (1-34) and zoledronic acid treatment on fracture healing in osteoporotic rats. Li YF, Zhou CC, Li JH, Luo E, Zhu SS, Feng G, Hu J. Osteoporos Int; 2012 Apr; 23(4):1463-74. PubMed ID: 21892678 [Abstract] [Full Text] [Related]
5. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). Nakajima A, Shimoji N, Shiomi K, Shimizu S, Moriya H, Einhorn TA, Yamazaki M. J Bone Miner Res; 2002 Nov; 17(11):2038-47. PubMed ID: 12412812 [Abstract] [Full Text] [Related]
7. The Effectiveness of Human Parathyroid Hormone and Low-Intensity Pulsed Ultrasound on the Fracture Healing in Osteoporotic Bones. Mansjur KQ, Kuroda S, Izawa T, Maeda Y, Sato M, Watanabe K, Horiuchi S, Tanaka E. Ann Biomed Eng; 2016 Aug; 44(8):2480-2488. PubMed ID: 26795976 [Abstract] [Full Text] [Related]
13. Treatment with parathyroid hormone hPTH(1-34), hPTH(1-31), and monocyclic hPTH(1-31) enhances fracture strength and callus amount after withdrawal fracture strength and callus mechanical quality continue to increase. Andreassen TT, Willick GE, Morley P, Whitfield JF. Calcif Tissue Int; 2004 Apr; 74(4):351-6. PubMed ID: 15255072 [Abstract] [Full Text] [Related]
14. Sequential treatment with basic fibroblast growth factor and parathyroid hormone restores lost cancellous bone mass and strength in the proximal tibia of aged ovariectomized rats. Wronski TJ, Ratkus AM, Thomsen JS, Vulcan Q, Mosekilde L. J Bone Miner Res; 2001 Aug; 16(8):1399-407. PubMed ID: 11499862 [Abstract] [Full Text] [Related]
18. Triweekly administration of parathyroid hormone (1-34) accelerates bone healing in a rat refractory fracture model. Kumabe Y, Lee SY, Waki T, Iwakura T, Takahara S, Arakura M, Kuroiwa Y, Fukui T, Matsumoto T, Matsushita T, Nishida K, Kuroda R, Niikura T. BMC Musculoskelet Disord; 2017 Dec 21; 18(1):545. PubMed ID: 29268728 [Abstract] [Full Text] [Related]
19. Abaloparatide, a PTH receptor agonist with homology to PTHrP, enhances callus bridging and biomechanical properties in rats with femoral fracture. Lanske B, Chandler H, Pierce A, Brown J, Ominsky M, Kostenuik P, Hattersley G. J Orthop Res; 2019 Apr 21; 37(4):812-820. PubMed ID: 30790359 [Abstract] [Full Text] [Related]
20. Combined antisclerostin antibody and parathyroid hormone (1-34) synergistically enhance the healing of bone defects in ovariectomized rats. Lin J, Wu J, Sun S, Chen K, Wu H, Lin R, Zhou C, Kong J, Zhou K, Shui X. Z Gerontol Geriatr; 2020 Mar 21; 53(2):163-170. PubMed ID: 31950363 [Abstract] [Full Text] [Related] Page: [Next] [New Search]